InvestorsHub Logo
Followers 49
Posts 3515
Boards Moderated 0
Alias Born 08/24/2005

Re: None

Tuesday, 11/17/2020 8:04:57 AM

Tuesday, November 17, 2020 8:04:57 AM

Post# of 977
ALXO > impressive ORR vs SOC (pg 32)...

https://ir.alxoncology.com/static-files/bee60c4d-90dc-4991-a6d5-efdb01c393f8

ALX Oncology (Nasdaq: ALXO) is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 checkpoint pathway and bridge the innate and adaptive immune system